Cargando…
Lauflumide (NLS-4) Is a New Potent Wake-Promoting Compound
Psychostimulants are used for the treatment of excessive daytime sleepiness in a wide range of sleep disorders as well as in attention deficit hyperactivity disorder or cognitive impairment in neuropsychiatric disorders. Here, we tested in mice the wake-promoting properties of NLS-4 and its effects...
Autores principales: | Luca, Gianina, Bandarabadi, Mojtaba, Konofal, Eric, Lecendreux, Michel, Ferrié, Laurent, Figadère, Bruno, Tafti, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104159/ https://www.ncbi.nlm.nih.gov/pubmed/30158846 http://dx.doi.org/10.3389/fnins.2018.00519 |
Ejemplares similares
-
Thalamic dual control of sleep and wakefulness
por: Gent, Thomas C., et al.
Publicado: (2018) -
Semiclassical focussing NLS
por: Kamvissis, S
Publicado: (2003) -
The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio
por: Holm, Anja, et al.
Publicado: (2022) -
Semiclassical NLS on the half line
por: Kamvissis, S
Publicado: (2002) -
Scope and Limitations of Exploiting the Ability of the Chemosensitizer NV716 to Enhance the Activity of Tetracycline Derivatives against Pseudomonas aeruginosa
por: Draveny, Margot, et al.
Publicado: (2023)